intercell 예문

예문모바일

In 1998, he and colleagues from IMP founded Intercell AG, a spin-off company.
Account created with a username promoting a company or organization, similar to User : Intercell, a past sock.
In 2013 Intercell merged with another European biotech, Vivalis, to create a successor company Valneva that focuses on vaccine development.
Three new trade pavilions were built . " Cellulose " changed its name to " Intercell ", and the cellular concrete factory was bought by the Ytong company.
Also, Pacific Telesis Group plans to use Ericsson's GSM in its PCS networks, and current auction bidders DCR, Omnipoint PCS Entrepenuers and Intercell Communications plan to use GSM, according to Ericsson.
Also, Pacific Telesis Group plans to use Ericsson's GSM in its PCS networks, and current auction bidders DCR, Omnipoint PCS Entrepreneurs and Intercell Communications plan to use GSM, according to Ericsson.
In September 2012 the Indian firm Biological E . Limited has launched an inactivated cell culture derived vaccine based on SA 14-14-2 strain which was developed in a technology transfer agreement with Intercell and is a thiomersal-free vaccine.
In case of interference in the selected frequency channel, the mobile terminal ( possibly from sussgestion by the base station ) can initiate either intracell handover, selecting another channel / transmitter on the same base, or intercell handover, selecting a different base station altogether.
The "'Roe approximate Riemann solver "', devised by Phil Roe, is an approximate Riemann solver based on the Godunov scheme and involves finding an estimate for the intercell numerical flux or Godunov flux F _ { i + \ frac { 1 } { 2 } } at the interface between two computational cells U _ { i } and U _ { i + 1 }, on some discretised space-time computational domain.
The patch technology underwent extensive evaluation in the context of a traveler's diarrhea vaccine which entered Phase 3 pivotal trials in 2009 . IOMAI was acquired by Intercell in 2008 and the technology was the subject of a development license to GSK in 2009 . Dr . Glenn pioneered needle free delivery to the skin and spawned general interest in skin-targeting vaccine technologies, including intradermal delivery and the use of the heat labile toxin as an adjuvant and the adjuvant patch.